Martek Biosciences Corporation

Martek's Clinical Trials of Plant Based DHA and ARA

Effect of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age

This trial is studying the effects of DHA on cognitive function in children 4 years of age. For more information visit ClinicalTrials.gov.

Memory Improvement With Docosahexaenoic Acid Study (MIDAS)

The MIDAS study is investigating the effect of docosahexaenoic acid (DHA) in improving cognitive functions in subjects with age-related cognitive decline. This study is currently recruiting patients. For more information visit ClinicalTrials.gov.

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

The purpose of this study is to determine whether chronic DHA (Docosahexaenoic Acid) supplementation slows the progression of cognitive and functional decline in mild to moderate Alzheimer's disease. For more information visit ClinicalTrials.gov.